Chesterford Research Park
@ChesterfordRP
Followers
812
Following
1K
Media
3K
Statuses
7K
Offering #biotech & #pharmaceutical R&D companies modern, dynamic and flexible facilities; from bespoke HQ buildings to fully fitted #laboratory & #office space
Cambridge
Joined March 2015
🧑🔬Our Sidney Sussex building will be ready for occupation in Q4!. The 55,764 sq ft of bespoke #laboratory and write-up space has been purpose-built to support #lifescience ventures as they transition from #startup to #scaleup. 📈. Find out more 👉
0
0
0
This @biomodalhq webinar explores the epigenetic analysis of the 6-base genome in Parkinson’s.
selectscience.net
Discover how biomodal’s 6-base genome enables analysis of 5mC and 5hmC epigenetic marks in Parkinson’s disease in this webinar with UCL's Burleen Chhatwal.
0
0
0
We’ve built a place where pioneering companies can grow, collaborate and recharge — all in one location. 🔬 State-of-the-art facilities .🌳 250 acres of stunning parkland .☕️ The Nucleus — our central hub with café and meeting space, . More:
0
0
0
Applications to the Cambridge NeuroWorks part time What If programme close on 29 August. Ideal for those wanting support to refine their hypotheses and plan next steps alongside other commitments.
🚀 Applications are open for the next Cambridge NeuroWorks What If cohort!. Passionate about tackling unmet needs in brain health? Explore bold neurotech ideas and take the next step in your innovation journey. 🔗 Info & apply:.
0
0
0
📢Vacancy alert!. Are you an early-career scientist looking for a new role? . Park occupier Isomerase is looking for a Synthetic Biology Research Associate. 🔗Job description and how to apply
0
1
0
ICYMI Microbiotica recently completed recruitment in its Phase 1b trial, COMPOSER-1, investigating MB310 in ulcerative colitis patients. Catch up on the news thanks to Business Weekly
businessweekly.co.uk
Microbiotica, a Cambridge-based clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), is making impressive progress.
0
0
0
If you have a knack for haiku then you could be published in Science ✍️.
#NextGenSci asks: In the form of a haiku, assess the state of science in your country. What are your country’s science-related strengths and weaknesses?. Submit your answer by 21 August for a chance to be published in Science:
0
0
0
A great opportunity for those working in childhood cancer.
If you're working on a therapeutic or target validation project for childhood cancer and want to progress your work, submit an expression of interest to C-Further, an international consortium we launched with @CR_Horizons. Deadline: 1 September.Apply now:
0
0
1
Bookings are now open for this year's Open Cambridge. From 12-21 September there are over 70 drop-in and bookable events celebrating local heritage and culture for all ages. Take a look at the programme 🔗 #OpenCambridge #VisitCambridge
0
0
0
Park-based @BrokenStringBio has renewed its commitment to the National Institute of Standards and Technology (NIST) Genome Editing Consortium. Find out more
brokenstringbio.com
BOSTON & CAMBRIDGE, England–(BUSINESS WIRE)–Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced its formal re-engagement as a member of the...
0
0
0
Another stunning selection of images from the @NaturePortfolio team.
July's best science images, as chosen by the Nature photo team, include a glow-in-the-dark marsupial showing off its luminous fur. The picture earned photographer Ben Alldridge a spot as a finalist in the Beaker Street Science Photography Prize 2025.
0
0
0
This year's New Scientist Live takes place over the weekend of 18-19 October and promises to be another fabulous festival of ideas and discoveries. It's for 'anyone and everyone who is curious about our brains, our bodies, our planet and our universe.'. 🔗
0
0
0
We're home to a community where biotech, pharma and tech pioneers thrive. 💡 Purpose-built labs and offices. 🌿 An environment that inspires. 🏃♂️ Wellness at your doorstep — with an on-site gym, golf course and nature trails. Find out more
0
0
0
Could 7,000 be the magic number? 🚶.
Don't worry if you don't walk 10,000 steps a day - falling short of that target still seems to bring serious health benefits.
0
0
0
The inaugural BioCentury Grand Rounds-Europe is coming to Cambridge in September. Attendees can expect cutting-edge discussions on disease biology, novel therapeutic modalities and enabling technologies. Find out more and secure your space
conferences.biocentury.com
Join BioCentury and Insights Partner McKinsey & Company for our 1st Grand Rounds-Europe, an interdisciplinary R&D forum at the interface of industry and academia.
0
1
0
Congratulations to Park occupiers Microbiotica on completing patient recruitment to its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis patients. Initial results are expected by the end of 2025. Full story 🔗
0
0
0
The Summit takes place in London on 16 September.
Now in its third year, the Charles River Laboratories-hosted Cell & Gene Therapy Summit continues to unite top minds across the CGT landscape for a one-day experience focused on tackling critical challenges, sparking innovation, and shaping the future of advanced therapies. ➡️
0
0
0
Discover more about the Illumina 5-base solution 👇.
Would you like to gain a deeper understanding of hidden regulators of disease in the genome and epigenome? Fiona Kaper shows how the Illumina 5-base solution can help you identify novel biomarkers for cancer and rare disease research:
0
0
0
📢Meet the Sidney Sussex Building – a brand‑new, sustainable hub designed to accelerate growth for ambitious biotech, pharma, and tech ventures!. Thinking about scaling your lab footprint? 🔗
0
0
0
📢Meet the Sidney Sussex Building – a brand‑new, sustainable hub designed to accelerate growth for ambitious biotech, pharma, and tech ventures!. Thinking about scaling your lab footprint? 🔗
0
0
0
Find out more about @BrokenStringBio's INDUCE-seq® at Cold Spring Harbor’s Genome Engineering: CRISPR Frontiers this week.
linkedin.com
Headed to Cold Spring Harbor’s Genome Engineering: CRISPR Frontiers this week? Don’t miss the chance to connect with our Chief Commercial Officer, Steve Becker. He'll be attending and ready to chat...
0
0
0